Material: Crystal

Pill-Themed Private Placement Deal Toy

Crystal deal toy commemorating a private placement by X4 Pharmaceuticals.

(21ALJ247)
2 Images
Financial tombstone marking a private placement by X4 Pharmaceuticals.

Hollywood Sign-Themed Deal Toy

Crystal deal toy commemorating a revolving credit facility provided for Westwood Financial, a Los Angeles-based real estate investment firm.

(20AKL001)
2 Images
Crystal deal tombstone marking a credit facility provided for Westwood Financial. The Los Angeles-based investment firm owns over 70 shopping centers across the U.S.

Sports Academy Crystal Tombstone

Crystal tombstone commemorating the investment by Man Capital in Right to Dream, which operates football (soccer) academies.

(21LSS157)
2 Images
Custom crystal marking an investment in Right to Dream football (soccer) academies. The investment will center on increasing youth opportunities in Egypt, Ghana, and Denmark.

Laptop-Themed Wrike Deal Toy

Crystal deal toy commemorating the acquisition of project management platform Wrike.

(21ALJ148)
2 Images
Computer laptop-themed deal toy marking the acquisition by software firm Citrix of Wrike. Based in San Jose, Wrike offers a SaaS project management platform.

Ergonomic Design Deal Toy

Custom deal toy marking the sale of a majority stake in Contour Design. The firm specializes ergonomic keyboard and mouse designs.

(21LJW030)
1 Image

Gas Pump-Themed Deal Tombstone

Crystal deal tombstone commemorating subordinated notes issued by Australian petroleum firm Ampol.

(21AKL212)
1 Image

City Skyline-Themed Deal Toy

Crystal deal toy commemorating Precinct Properties New Zealand’s move to bring management in-house. The real estate investment trust (REIT) invests in properties in Auckland and Wellington.

(21ALJ264)
1 Image

Title Company Acquisition Deal Toy

Crystal deal toy commemorating the acquisition of Overland Park, Kansas-based Continental Title Company.

(21ALJ241)
1 Image

Pharma Royalty Interest Deal Toy

Crystal deal toy marking the sale of a royalty interest in OXLUMO. OXLUMO has been approved by both the Food and Drug Administration (FDA), and the European Medicine’s Agency (EMA).

(21ALJ215)
1 Image